DE19681529D2 - Pharmaceutical dosage form - Google Patents

Pharmaceutical dosage form

Info

Publication number
DE19681529D2
DE19681529D2 DE19681529T DE19681529T DE19681529D2 DE 19681529 D2 DE19681529 D2 DE 19681529D2 DE 19681529 T DE19681529 T DE 19681529T DE 19681529 T DE19681529 T DE 19681529T DE 19681529 D2 DE19681529 D2 DE 19681529D2
Authority
DE
Germany
Prior art keywords
dosage form
pharmaceutical dosage
pharmaceutical
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE19681529T
Other languages
German (de)
Inventor
Dieter Mueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from BR9612652A external-priority patent/BR9612652A/en
Application granted granted Critical
Publication of DE19681529D2 publication Critical patent/DE19681529D2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N37/00Details not covered by any other group of this subclass
    • G01N37/005Measurement methods not based on established scientific theories
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00Magnetotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00Magnetotherapy
    • A61N2/004Magnetotherapy specially adapted for a specific therapy
    • A61N2/008Magnetotherapy specially adapted for a specific therapy for pain treatment or analgesia
DE19681529T 1996-06-29 1996-06-29 Pharmaceutical dosage form Expired - Lifetime DE19681529D2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
BR9612652A BR9612652A (en) 1996-06-29 1996-06-29 Form of pharmaceutical administration
PCT/EP1996/002849 WO1998000198A1 (en) 1996-06-29 1996-06-29 Pharmaceutical administration form
CN96180357.6A CN1255194C (en) 1996-06-29 1996-06-29 Pharmaceutical administration form
CA002259333A CA2259333A1 (en) 1996-06-29 1996-06-29 Pharmaceutical administration form

Publications (1)

Publication Number Publication Date
DE19681529D2 true DE19681529D2 (en) 1999-10-14

Family

ID=27425268

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681529T Expired - Lifetime DE19681529D2 (en) 1996-06-29 1996-06-29 Pharmaceutical dosage form

Country Status (5)

Country Link
EP (1) EP0907388A1 (en)
CN (1) CN1255194C (en)
CA (1) CA2259333A1 (en)
DE (1) DE19681529D2 (en)
WO (1) WO1998000198A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69119869T2 (en) * 1990-11-23 1996-12-12 American Cyanamid Co Chimeric fibroblast growth factor
WO2002033920A1 (en) 2000-10-16 2002-04-25 Telefonaktiebolaget Lm Ericsson (Publ) Dc-offset compensation
GB2428580A (en) * 2005-07-22 2007-02-07 Cwm Dulas Corp Ltd Substance intolerance testing by measuring patients response to electric stimulation at characteristic frequencies of that substance
WO2011062518A2 (en) * 2009-11-20 2011-05-26 Germanov Evgeny Pavlovich Method for the remote transmission of an energy information signal from animate and inanimate objects and energy information signal converter
WO2015082964A1 (en) * 2013-12-06 2015-06-11 Germanov Evgenij Pavlovich Device for the remote transmission of a representative value of electromagnetic radiation emitted by a material and methods for operating the device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3419055A1 (en) * 1984-05-22 1985-11-28 Hans-Günter 2300 Altenholz Berner MAGNETIC FILM COVER
DE4229921A1 (en) * 1992-09-08 1993-03-04 Wolfgang Dipl Phys Dr R Ludwig Medical data electronic and electronic storage and transmission method - using material characteristic frequencies activated by excitation with generator tapped by Fourier analyser across coils for medical therapeutic purposes
US5441528A (en) * 1992-09-25 1995-08-15 Symtonic, S.A. Method and system for applying low energy emission therapy
AU4095393A (en) * 1993-04-23 1994-11-21 Sergei Ivanovich Petrenko Device for altering the activity of a biological cell
DE4446479A1 (en) * 1994-12-23 1996-06-27 Ulrich Dr Warnke Procedure to stimulate cell structures of living organisms

Also Published As

Publication number Publication date
CN1224366A (en) 1999-07-28
CN1255194C (en) 2006-05-10
EP0907388A1 (en) 1999-04-14
CA2259333A1 (en) 1998-01-08
WO1998000198A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
DE69525148D1 (en) PHARMACEUTICAL FORMULATION
ATE312602T1 (en) EXTENDED-RELEASE ORAL PHARMACEUTICAL DOSAGE FORM
DE69812089D1 (en) PHARMACEUTICAL OMEPRAZOLE FORMULATION
DE69814091D1 (en) PRE-ICONAZOLE CONTAINING PHARMACEUTICAL PREPARATIONS
DE69726015D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING KOENZYM Q-10
EE200000395A (en) Oral pharmaceutical pulsatile dosage form
DE59712959D1 (en) ORAL PHARMACEUTICAL PREPARATION CONTAINING IBANDRONAT
IS4886A (en) Dosage unit for unit dose
DE69704965T2 (en) Dosage dispenser
BR9706897B1 (en) pharmaceutical dosage form.
DK0754061T3 (en) New oral pharmaceutical dosage form
ATE222751T1 (en) PHARMACEUTICAL AEROSOL COMPOSITION
DE59915033D1 (en) Pharmaceutical preparation
DE59910298D1 (en) PHARMACEUTICAL LEVOTHYROXINE PREPARATION
DE59801987D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PEPTICHEMIO
DE4294862T1 (en) Pharmaceutical composition
DE69614407D1 (en) PHARMACEUTICAL COMPOSITIONS
ID16781A (en) PHARMACEUTICAL FORMULATIONS
ATE295150T1 (en) PHARMACEUTICAL COMPOSITIONS
DE69622391T2 (en) ABUSE VISIBLE MAKING PHARMACEUTICAL DOSAGE
ATE208364T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A-OXO-BUTANIC ACIDS
EE9800275A (en) Prolonged-release pharmaceutical preparations containing misolastin
ATE269695T1 (en) PHARMACEUTICAL PELLETS
FI973230A (en) New pharmaceutical formulation
DE19681529D2 (en) Pharmaceutical dosage form

Legal Events

Date Code Title Description
8130 Withdrawal